Venous thromboembolism is associated with worse survival in patients with pancreatic ductal adenocarcinoma receiving ...

The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.

The majority of fatal cases of pulmonary embolism in hospitalized patients occur in acutely ill, medically treated patients. Current guidelines, based on a large number of prospective, randomized, ...

This the first study to evaluate the risk for venous thromboembolism by lupus nephritis class, according to investigators. Venous thromboembolism (VTE) among patients with lupus nephritis (LN) is not ...

SonoVascular, Inc., a clinical stage medical device company focused on transforming the treatment of venous thromboembolism (VTE) with its SonoThrombectomy(TM) System, has completed the first close of ...

Please provide your email address to receive an email when new articles are posted on . In patients with rheumatoid arthritis, risk of venous thromboembolism was higher in those taking 10 mg of ...

Please provide your email address to receive an email when new articles are posted on . Patients with RA taking tofacitinib 5 mg did not have elevated risk for cardiovascular events compared with ...

September 23, 2011 (London, United Kingdom) — Advisors for the European Medicines Agency (EMA) have paved the way for two new indications for rivaroxaban (Xarelto, Bayer) in Europe. The EMA's ...

Annual costs of VTE in the United States are substantial and have previously been estimated to be as high as $69.3 billion. 6,7 A study by Mahan et al in 2012 was performed to assess annual US ...

Patients with atopic dermatitis (AD) appear to be at increased risk of venous thromboembolism (VTE). That's the key finding in a systemic review and meta-analysis published in the Journal of ...